Activist Investor 13D, 13G Filings


This page shows a list of all the recent 13D/G filings made by Takeda Pharmaceutical Co Ltd. Schedule 13D is commonly referred to as a “beneficial ownership report.” The term "beneficial owner" is defined under SEC rules. It includes any person who directly or indirectly shares voting power or investment power (the power to sell the security).

When a person or group of persons acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities, they are required to file a Schedule 13D within ten days after the purchase. Click the link icon to see the full transaction history.

DateForm Target Prev
Shares
Current
Shares
Change
(Percent)
Ownership
(Percent)
Change
(Percent)
2018‑01‑12 SC 13D TGXSF / Tigenix Sa 56,336,422 20.2
2017‑08‑10 SC 13D THLD / Threshold Pharmaceuticals, Inc. 10.9
2017‑02‑16 SC 13D/A ARIA / ARIAD Pharmaceuticals, Inc. 13,227,804 100 -100.00 100.0 1,370.59
2017‑01‑18 SC 13D ARIA / ARIAD Pharmaceuticals, Inc. 13,227,804 6.8